AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
Jun 27, 2018
30583_dirs_2018-06-26_1ecf6bf7-f5e8-46bc-bbdf-50239af5e90e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-06-22
Reporting Person: Mueller Brian (SVP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-22 | Common Stock | S | 654 | $99.5 | Disposed | 12375 | Direct |
| 2018-06-22 | Common Stock | M | 2491 | $28.23 | Acquired | 14866 | Direct |
| 2018-06-22 | Common Stock | S | 2491 | $99.5 | Disposed | 12375 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-22 | Stock Option (Right to buy Common Stock) | $28.23 | M | 2491 | Disposed | 2021-05-30 | Common Stock (2491) | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.
F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19